CD4 and neoplasm: In the tumor microenvironment (TME), 5%–30% of CD4+Foxp3+ Treg cells have been observed to highly express granzyme B—a feature absent in Treg cells from some mouse models—suggesting that granzyme B production enables Tregs to kill NK cells and CD8+ T cells.